News
Consolidated sales amounted to €2,044 million in the first-half of 2025 from €1,902 million in the prior year period, a +9.4% like-for-like growth.
Swipe to discover more
-
OhioHealth Partners with bioMérieux as Newest Global Antimicrobial Stewardship Center of Excellence
OhioHealth joins bioMérieux’s AMS Centers of Excellence, advancing diagnostics to fight antimicrobial resistance and improve patient outcomes.
-
« Always consider sepsis in the context of infection. »
Patient associations across the globe are actively engaged in promoting this critical message to both healthcare professionals and the broader public. We met with Dr Rafael Moraes from ILAS, Melissa Mead from The UK Sepsis Trust and Thomas Heymann from Sepsis Alliance to learn more about their actions. -
bioMérieux Showcases Diagnostic Innovation and AMR Leadership at ADLM 2025
bioMérieux reaffirmed its role as the global leader in infectious disease diagnostics and antimicrobial resistance (AMR) advocacy at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) Scientific Meeting and Clinical Lab Expo.
Enabling Decision-Making
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19